Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt-Hogg-Dubé syndrome

Pathology International

Volumn 63, Issue 1, 2013, Pages 45-55

  Nishii, Teppei ^a   Tanabe, Mikiko ^a   Tanaka, Reiko ^c   Matsuzawa, Tetsuhiro ^c   Okudela, Koji ^b   Nozawa, Akinori ^a   Nakatani, Yukio ^d   Furuya, Mitsuko ^b,d  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Birt Hogg Dub syndrome; Exon skipping; mTOR signaling; Pneumothorax; Pulmonary cysts

Indexed keywords

ESTRONE; GENOMIC DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BINDING SITE; BIRT HOGG DUBE SYNDROME; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRON; LUNG ALVEOLUS CELL; LUNG CYST; LUNG RESECTION; PNEUMOTHORAX; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; THORACOSCOPY; WESTERN BLOTTING;

ADULT; BIRT-HOGG-DUBE SYNDROME; CYSTS; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LUNG; LUNG DISEASES; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; PNEUMOTHORAX; PROTO-ONCOGENE PROTEINS; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 84873094749     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12028     Document Type: Article

References (27)

1. Khoo SK, Bradley M, Wong FK, Hedblad MA, Nordenskjold M, Teh BT. Birt-Hogg-Dube syndrome: Mapping of a novel hereditary neoplasia gene to chromosome 17p12-q11.2. Oncogene 2001; 20: 5239-5242.
2. Schmidt LS, Warren MB, Nickerson ML etal. Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2. Am J Hum Genet 2001; 69: 876-882.
3. Nickerson ML, Warren MB, Toro JR etal. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell 2002; 2: 157-164.
4. Baba M, Hong SB, Sharma N etal. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci U S A 2006; 103: 15552-15557.
5. Hasumi H, Baba M, Hong SB etal. Identification and characterization of a novel folliculin-interacting protein FNIP2. Gene 2008; 415: 60-67.
6. Takagi Y, Kobayashi T, Shiono M etal. Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel Fnip1-like (FnipL/Fnip2) protein. Oncogene 2008; 27: 5339-5347.
7. Toro JR, Wei MH, Glenn GM etal. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: A new series of 50 families and a review of published reports. J Med Genet 2008; 45: 321-331.
8. Linehan WM, Srinivasan R, Schmidt LS. The genetic basis of kidney cancer: A metabolic disease. Nat Rev Urol 2010; 7: 277-285.
9. Hartman TR, Nicolas E, Klein-Szanto A etal. The role of the Birt-Hogg-Dube protein in mTOR activation and renal tumorigenesis. Oncogene 2009; 28: 1594-1604.
10. Kouchi M, Okimoto K, Matsumoto I, Tanaka K, Yasuba M, Hino O. Natural history of the Nihon (Bhd gene mutant) rat, a novel model for human Birt-Hogg-Dube syndrome. Virchows Arch 2006; 448: 463-471.
11. Vocke CD, Yang Y, Pavlovich CP etal. High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors. J Natl Cancer Inst 2005; 97: 931-935.
12. van Steensel MA, Verstraeten VL, Frank J etal. Novel mutations in the BHD gene and absence of loss of heterozygosity in fibrofolliculomas of Birt-Hogg-Dube patients. J Invest Dermatol 2007; 127: 588-593.
13. Koga S, Furuya M, Takahashi Y etal. Lung cysts in Birt-Hogg-Dube syndrome: Histopathological characteristics and aberrant sequence repeats. Pathol Int 2009; 59: 720-728.
14. Furuya M, Tanaka R, Koga S etal. Pulmonary Cysts of Birt-Hogg-Dube Syndrome: A Clinicopathologic and Immunohistochemical Study of 9 Families. Am J Surg Pathol 2012; 36: 589-600.
15. Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 2005; 37: 19-24.
16. Baba M, Furihata M, Hong SB etal. Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J Natl Cancer Inst 2008; 100: 140-154.
17. Hudon V, Sabourin S, Dydensborg AB etal. Renal tumour suppressor function of the Birt-Hogg-Dube syndrome gene product folliculin. J Med Genet 2010; 47: 182-189.
18. Chen J, Futami K, Petillo D etal. Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS One 2008; 3: e3581.
19. Gunji Y, Akiyoshi T, Sato T etal. Mutations of the Birt Hogg Dube gene in patients with multiple lung cysts and recurrent pneumothorax. J Med Genet 2007; 44: 588-593.
20. Kunogi M, Kurihara M, Ikegami TS etal. Clinical and genetic spectrum of Birt-Hogg-Dube syndrome patients in whom pneumothorax and/or multiple lung cysts are the presenting feature. J Med Genet 2010; 47: 281-287.
21. Hasumi Y, Baba M, Ajima R etal. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc Natl Acad Sci U S A 2009; 106: 18722-18727.
22. Preston RS, Philp A, Claessens T etal. Absence of the Birt-Hogg-Dube gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility. Oncogene 2011; 30: 1159-1173.
23. Hayashi M, Takayanagi N, Ishiguro T, Sugita Y, Kawabata Y, Fukuda Y. Birt-Hogg-Dube syndrome with multiple cysts and recurrent pneumothorax: Pathological findings. Intern Med 2010; 49: 2137-2142.
24. Shaw RJ, Bardeesy N, Manning BD etal. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 2004; 6: 91-99.
25. Katajisto P, Vaahtomeri K, Ekman N etal. LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis. Nat Genet 2008; 40: 455-459.
26. Bissler JJ, McCormack FX, Young LR etal. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 2008; 358: 140-151.
27. McCormack FX, Inoue Y, Moss J etal. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 2011; 364: 1595-1606.